Understanding the regulation of GDF11 signaling in the context of the gastrointestinal diseases
2020/39/O/NZ7/00604
Keywords
Descriptors
- NZ7_014: Farmacja, farmakoterapia, farmakologia
- NZ3_007: Przekaźnictwo sygnału
- NZ4_004: Patofizjologia ogólna
Panel
NZ7 – Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution
Uniwersytet Medyczny w Łodzi, Wydział Lekarski
Voivodeship: łódzkie
Principal investigator (from the host institution)
Number of co-investigators in the project: 2
Call
PRELUDIUM BIS 2 – announced on 2020-09-15
- Amount awarded
- 540 800 PLN
- Project start date
- 2021-10-01
- Project end date
- 2025-09-30
- Project duration
- 48 months (the same as in the proposal)
- Project status
- Project completed
Project description
Download the project description in a pdf file
Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Information in the final report
Publication in academic press/journals (2)
-
GDF11 as a friend or an enemy in the cancer biology?
- Authors:
- Wojciech Król, Weronika Machelak, Marta Zielińska
- Academic press:
- Biochimica et Biophysica Acta-Reviews on Cancer (year: 2023, volume: 1878, pages: 46033), Publisher: Elsevier
- Status:
- Published
- DOI:
- 10.1016/j.bbcan.2023.188944 – link to the publication
-
The role of GDF11 during inflammation - An overview
- Authors:
- Weronika Machelak, Adrian Szczepaniak,Damian Jacenik,Marta Zielińska
- Academic press:
- Life Sciences (year: 2023, volume: 322, pages: 46030), Publisher: Elsevier
- Status:
- Published
- DOI:
- 10.1016/j.lfs.2023.121650 – link to the publication